|
Volumn 38, Issue SUPPL. 2, 2002, Pages
|
Nitric oxide inhibition and renal alterations
a a |
Author keywords
Angiotensin II; Calcium blockers; Endothelin; Prevention; Sympathetic nervous system; Treatment
|
Indexed keywords
ANGIOTENSIN;
ARGININE;
BOSENTAN;
CALCIUM ANTAGONIST;
CALCIUM CHANNEL BLOCKING AGENT;
CANDESARTAN;
CAPTOPRIL;
CILAZAPRIL;
CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL);
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRILAT;
ENDOTHELIN;
ENDOTHELIN A RECEPTOR ANTAGONIST;
ENDOTHELIN B RECEPTOR ANTAGONIST;
HYDRALAZINE;
IMIDAPRIL;
LOSARTAN;
N(G) NITROARGININE METHYL ESTER;
NIFEDIPINE;
NITRIC OXIDE;
PHOSPHORAMIDON;
QUINAPRIL;
VERAPAMIL;
ARTERIAL PRESSURE;
CONFERENCE PAPER;
HUMAN;
HYPERTENSION;
KIDNEY BLOOD FLOW;
KIDNEY DISEASE;
KIDNEY FUNCTION;
NATRIURESIS;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
|
EID: 0036134933
PISSN: 01602446
EISSN: None
Source Type: Journal
DOI: 10.1097/00005344-200111002-00016 Document Type: Conference Paper |
Times cited : (30)
|
References (22)
|